Home
Conditions
Neoplasm Metastasis

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Testing the Sequential Combination of the Anti-cancer Drugs Olaparib Followed by Adavosertib (AZD1775) in Patients With Advanced Solid Tumors With Selected Mutations and PARP Resistance, STAR Study

NCT04197713

Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +6 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

NCT03743649

Conditions: Confusion, Delirium, Disease Attributes, +15 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States

Hosptial de Cancer de Barretos Barretos, São Paulo, Brazil

View Trial Details

Active, Not Recruiting

A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer

NCT04214288

Conditions: Advanced ER-Positive HER2-Negative Breast Cancer, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Long Beach, California, United States

Research Site Fort Myers, Florida, United States

Research Site St. Petersburg, Florida, United States

View all 85 locations

View Trial Details

Active, Not Recruiting

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

NCT02671435

Conditions: Advanced Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Scottsdale, Arizona, United States

Research Site Duarte, California, United States

Research Site La Jolla, California, United States

View all 49 locations

View Trial Details

Active, Not Recruiting

Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes

NCT02286687

Conditions: ATM Gene Mutation, Advanced Malignant Neoplasm, BRCA1 Gene Mutation, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

NCT00929214

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors

NCT04266912

Conditions: Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, Neoplasms, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer

NCT06107868

Conditions: Adnexal Diseases, Advanced Cancer, Endocrine Gland Neoplasms, +22 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

The Efficacy of Tislelizumab Combined With Albumin-bound Paclitaxel and Platinum-based Chemotherapy in Patients With KRAS-mutated Lung Cancer

NCT07638878

Conditions: Lung Cancer (Locally Advanced or Metastatic), Lung Diseases, Lung Neoplasms, +9 more
Locations: The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity

NCT00393783

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Neoplasm Metastasis

Neoplasm Metastasis trial results

Related conditions